Global and Europe Drugs of Nervous System Market - Analysis and Outlook to 2022

SKU ID : EUR- 10462636

Publishing Date : 20-Jul-2017

No. of pages : 130

PRICE
2960
5920

  • This report presents a comprehensive overview of the Drugs of Nervous System market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
    This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Drugs of Nervous System industry.
    This report focus Global and Europe market, it covers details players regions product type and other details as following:

    Key Players
    Zhejiang Chiral Medicine Chemicals
    Gedeon Richter Plc.Hungary
    S.P. QUIMICA, S.A. ES 43330 Riudoms
    Janssen Pharmaceutica N.V. Belgium
    Moehs Iberica S.L. ES 08191 Rubi
    Sanofi Aventis Deutschland France
    TEVA CZECH INDUSTRIES Opava-Komarov
    Taiwan Biotech Co.Ltd
    PATHEON AUSTRIA GMBH & CO. KG AT Linz
    GlaxoSmithKline Pharmaceuticals S.A.Poland
    ALKALOIDA CHEMICAL Tiszavasvari
    Actavis hf. Iceland
    Siegfried Ltd CH 4800 Zofingen
    UCB Pharma S.A.Belgium
    KATWIJK CHEMIE BV NL BA Katwijk ZH
    Janssen-Cilag AG Puerto Rico
    F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
    Bayer Vital GmbH Germany
    Ergypharm FR 67452 Mundolsheim
    Roquette Freres France
    HARMAN FINOCHEM LIMITED IN Mumbai
    Pfizer Pharmaceuticals Inc.
    MSD PHARMA (SINGAPORE) PTE. LTD.Italy
    Sawai Pharmaceutical Co.,Ltd.
    Orion Corporation Finland
    Nichi-iko Pharmaceutical Co.,Ltd
    Gedeon Richter Plc. Hungary
    Novartis Farma S.P.A. Italy

    Key Regions
    Europe
    ----Germany
    ----United Kingdom
    ----France
    ----Italy
    ----Spain
    ----Russia
    ----Netherland
    ----Poland
    ----Others
    United States
    China
    Japan
    India
    Others

    Key Product Type
    by Product Antiparkinsonism drugs
    L-Dopa,
    Carbidopa,
    Benserazide,
    Sinemet,
    Selegiline

    by Product Antimyasthenics
    Neostigmine,
    Neostigmine Methylsulfate,
    Pyridostigmine Bromide,
    Galanthamine,
    Edrophonium Chloride

    by Product Antiepileptics
    Phenytoin Sodium,
    Carbamazepine,
    Phenobarbital,
    Primidone,
    Ethosuximide

    by Product Cerebrovascular disease drugs
    Nimodipine,
    Carfergot,
    Mannitol,
    Acetazolamide,
    Piracetam

    by Product Sedative-hypnotic drugs
    Diazepam,
    Chlordiazepoxide,
    Oxazepam,
    Nitrazepam,
    Flunitrazepam

    Key Applications
    Pharmacy
    Hospital
    Department of psychiatry
    Department of Encephalopathy
    Department of neurology


    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports